Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.
[CanLyme note: More evidence that the current two tier testing model imposed upon Canadians is incapable of detecting the genetic diversity of Borrelia we have, just as Health Canada published 1.5 years ago, yet Infectious Disease doctors, including paediatricians refuse to see anyone without a positive two tier test… stunningly unethical and ‘to hell with the patient,…
